Trial Search Results
Advanced Gastrointestinal Endoscopic Imaging
To develop new methods to detect malignant and premalignant conditions of the gastrointestinal tract.
Stanford is currently not accepting patients for this trial.
Collaborator: National Cancer Institute (NCI)
- Device: Dual axis endoscopic microscope
- Device: wide field fluorescence system
- Device: CellVizio
- Drug: fluorescent Peptide
- Drug: fluorescein
- Drug: indocyanine green
Inclusion Criteria:patients be at least 18 years of age,
All ethnic backgrounds will be considered.
Patients who are scheduled for endoscopy by one of the investigators will be asked if they
are interested in participating in the study.
The study will be open to all patients undergoing endoscopy that do not have exclusion
criteria. We will ask all patients if they are participating in any other studies. If they
are participating in any other study then we will ask them for more information to
determine whether there could be any harm from participating in both studies and if there
is then they will not be enrolled.
Exclusion Criteria:Patients with unstable vital signs will not be included.
Ages Eligible for Study
18 Years - N/A
Genders Eligible for Study